Drugs / Dexibuprofen
Dexibuprofen
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02956512 | Mar → Jul 2019 | — | Apsen Farmaceutica S.A. | Completed | No outcome recorded |
| Phase 1 | NCT02956525 | Apr → Jul 2018 | — | Apsen Farmaceutica S.A. | Completed | No outcome recorded |
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT03852459 | Jan 2018 → Apr 2019 | — | Aponia Laboratories, Inc. | Completed | Missed primary |
| Phase 31 trial | ||||||
| Phase 3 | NCT00812422 | Feb 2008 → May 2009 | respiratory tract infectious disorder | Inje University | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01066676 | Oct 2009 → Jun 2012 | osteoarthritis | Gebro Pharma GmbH | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT02324985 Comparator | Jan → Jul 2015 | — | Aponia Laboratories, Inc. | Completed | No outcome recorded |
| — | NCT01638962 Comparator | Aug 2012 → Aug 2015 | osteoarthritis, knee | University of Southern Denmark | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dexibuprofen | “Dexibuprofen” NCT01638962 ↗ |
| Known as | AP0302 | “Phase II Study of the Effects of AP0302 5% (S-Ibuprofen Topical Gel 5%) Versus the Vehicle Control on Delayed Onset Muscle Soreness of the Elbow Flexors” NCT02324985 ↗1“S-Ibuprofen Topical Gel 5% (AP0302)” NCT03852459 ↗ |
| Known as | Dexibuprofene | ChEMBL registry synonym — accepted as the source's own label CHEMBL175 ↗ |
| Known as | Dexibuprofeno | ChEMBL registry synonym — accepted as the source's own label CHEMBL175 ↗ |
| Known as | NSC-759814 | ChEMBL registry synonym — accepted as the source's own label CHEMBL175 ↗ |
| Known as | S-Ibuprofen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03852459 ↗ |
| Known as | Seractil | ChEMBL registry synonym — accepted as the source's own label CHEMBL175 ↗ |
| Modality | Small molecule | — CHEMBL175 ↗ |
| Route | Oral | “400mg powder for oral suspension” NCT01066676 ↗ |